Samer Gawrieh, MD
Professor of Medicine
Hepatology Research Fellowship Program Director
- Address
-
Rotary Building
702 Rotary Circle, Suite 225
RO 207
Indianapolis, IN 46202-5175 - PubMed:
-
Bio
Dr. Gawrieh is a Professor of Medicine and the Director of the Hepatology Research and Clinical Fellowship Program in the Division of Gastroenterology and Hepatology at Indiana University School of Medicine. He is a nationally recognized expert in liver disease and has received NIH funding to study metabolic-dysfunction and alcohol-associated liver disease. His clinical and translational research investigates the genetic and environmental factors affecting these conditions as well as their diagnostics and therapeutics. Dr. Gawrieh also serves as the Clinical Director of the Data Coordinating Center for the NIH-sponsored Alcoholic Hepatitis Network, a national network of leading academic centers in the US that studies different aspects and therapeutics of alcohol-associated hepatitis.
Dr. Gawrieh is certified by the American Board of Internal Medicine in Internal Medicine, Gastroenterology, and Transplant Hepatology.
| Year | Degree | Institution |
|---|---|---|
| 2004 | Fellowship | Mayo Clinic |
| 2003 | Fellowship | Medical College of Wisconsin |
| 1998 | Residency | Cook County Hospital |
| 1996 | MD | University of Aleppo |
Significant Dose-Response Association of Physical Activity and Diet Quality With Mortality in Adults With Suspected NAFLD in a Population Study.
Vilar-Gomez E; Vuppalanchi R; Gawrieh S; Pike F; Samala N; Chalasani N; The American journal of gastroenterology 2023 Mar 27
Vilar-Gomez E; Vuppalanchi R; Gawrieh S; Pike F; Samala N; Chalasani N; The American journal of gastroenterology 2023 Mar 27
Phosphatidylethanolamines Are Associated with Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Adults and Induce Liver Cell Metabolic Perturbations and Hepatic Stellate Cell Activation.
Shama S; Jang H; Wang X; Zhang Y; Shahin NN; Motawi TK; Kim S; Gawrieh S; Liu W; International journal of molecular sciences 2023 Jan 5
Shama S; Jang H; Wang X; Zhang Y; Shahin NN; Motawi TK; Kim S; Gawrieh S; Liu W; International journal of molecular sciences 2023 Jan 5
Saroglitazar, a Dual PPAR a/? Agonist, Improves Atherogenic Dyslipidemia in Patients With Non-Cirrhotic Nonalcoholic Fatty Liver Disease: A Pooled Analysis.
Siddiqui MS; Parmar D; Sheikh F; Sarin SK; Cisneros L; Gawrieh S; Momin T; Duseja A; Sanyal AJ; Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2023 Jan 31
Siddiqui MS; Parmar D; Sheikh F; Sarin SK; Cisneros L; Gawrieh S; Momin T; Duseja A; Sanyal AJ; Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2023 Jan 31
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population.
Vilar-Gomez E; Vuppalanchi R; Gawrieh S; Samala N; Chalasani N; Hepatology (Baltimore, Md.) 2023 Jan 3
Vilar-Gomez E; Vuppalanchi R; Gawrieh S; Samala N; Chalasani N; Hepatology (Baltimore, Md.) 2023 Jan 3
Design of a multicenter randomized clinical trial for treatment of Alcohol-Associated Hepatitis.
Tu W; Gawrieh S; Dasarathy S; Mitchell MC; Simonetto DA; Patidar KR; McClain CJ; Bataller R; Szabo G; Tang Q; Barton BA; Radaeva S; Sanyal AJ; Shah V; Alcoholic Hepatitis Network (AlcHepNet) Investigators; Contemporary clinical trials communications 2023 Jan 18
Tu W; Gawrieh S; Dasarathy S; Mitchell MC; Simonetto DA; Patidar KR; McClain CJ; Bataller R; Szabo G; Tang Q; Barton BA; Radaeva S; Sanyal AJ; Shah V; Alcoholic Hepatitis Network (AlcHepNet) Investigators; Contemporary clinical trials communications 2023 Jan 18
Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study.
Gawrieh S; Lake JE; Debroy P; Sjoquist JA; Robison M; Tann M; Akisik F; Bhamidipalli SS; Saha CK; Zachary K; Robbins GK; Gupta SK; Chung RT; Chalasani N; Corey KE; Hepatology (Baltimore, Md.) 2023 Feb 22
Gawrieh S; Lake JE; Debroy P; Sjoquist JA; Robison M; Tann M; Akisik F; Bhamidipalli SS; Saha CK; Zachary K; Robbins GK; Gupta SK; Chung RT; Chalasani N; Corey KE; Hepatology (Baltimore, Md.) 2023 Feb 22
Non-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virus.
Gawrieh S; Corey KE; Lake JE; Samala N; Desai AP; Debroy P; Sjoquist JA; Robison M; Tann M; Akisik F; Bhamidipalli SS; Saha CK; Zachary K; Robbins GK; Gupta SK; Chung RT; Chalasani N; PloS one 2023 Feb 10
Gawrieh S; Corey KE; Lake JE; Samala N; Desai AP; Debroy P; Sjoquist JA; Robison M; Tann M; Akisik F; Bhamidipalli SS; Saha CK; Zachary K; Robbins GK; Gupta SK; Chung RT; Chalasani N; PloS one 2023 Feb 10
Critical Illness Cholangiopathy in COVID-19 Long-Haulers.
Saleem N; Li BH; Vuppalanchi R; Gawrieh S; Gromski MA; Techniques and innovations in gastrointestinal endoscopy 2022 May 21
Saleem N; Li BH; Vuppalanchi R; Gawrieh S; Gromski MA; Techniques and innovations in gastrointestinal endoscopy 2022 May 21
Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms.
Woreta TA; Van Natta ML; Lazo M; Krishnan A; Neuschwander-Tetri BA; Loomba R; Mae Diehl A; Abdelmalek MF; Chalasani N; Gawrieh S; Dasarathy S; Vuppalanchi R; Siddiqui MS; Kowdley KV; McCullough A; Terrault NA; Behling C; Kleiner DE; Fishbein M; Hertel P; Wilson LA; Mitchell EP; Miriel LA; Clark JM; Tonascia J; Sanyal AJ; NASH Clinical Research Network; PloS one 2022 Apr 15
Woreta TA; Van Natta ML; Lazo M; Krishnan A; Neuschwander-Tetri BA; Loomba R; Mae Diehl A; Abdelmalek MF; Chalasani N; Gawrieh S; Dasarathy S; Vuppalanchi R; Siddiqui MS; Kowdley KV; McCullough A; Terrault NA; Behling C; Kleiner DE; Fishbein M; Hertel P; Wilson LA; Mitchell EP; Miriel LA; Clark JM; Tonascia J; Sanyal AJ; NASH Clinical Research Network; PloS one 2022 Apr 15
Changing Trends of Cirrhotic and Noncirrhotic Hepatocellular Carcinoma in the Era of Directly-Acting Antiviral Agents.
Mathur K; Mazhar A; Patel M; Dakhoul L; Burney H; Liu H; Nephew L; Chalasani N; deLemos A; Gawrieh S; Clinical and translational gastroenterology 2021 Nov 3
Mathur K; Mazhar A; Patel M; Dakhoul L; Burney H; Liu H; Nephew L; Chalasani N; deLemos A; Gawrieh S; Clinical and translational gastroenterology 2021 Nov 3
Role of the Surgical Pathologist in Diagnosis of Drug-induced Liver Injury: Recognizing Specific Patterns of Drug Injury.
Chopra S; Gawrieh S; Vuppalanchi R; Saxena R; Advances in anatomic pathology 2021 Nov 1
Chopra S; Gawrieh S; Vuppalanchi R; Saxena R; Advances in anatomic pathology 2021 Nov 1
Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort.
Harrison SA; Gawrieh S; Roberts K; Lisanti CJ; Schwope RB; Cebe KM; Paradis V; Bedossa P; Aldridge Whitehead JM; Labourdette A; Miette V; Neubauer S; Fournier C; Paredes AH; Alkhouri N; Journal of hepatology 2021 Mar 18
Harrison SA; Gawrieh S; Roberts K; Lisanti CJ; Schwope RB; Cebe KM; Paradis V; Bedossa P; Aldridge Whitehead JM; Labourdette A; Miette V; Neubauer S; Fournier C; Paredes AH; Alkhouri N; Journal of hepatology 2021 Mar 18
Saroglitazar, a PPAR-a/? Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial.
Gawrieh S; Noureddin M; Loo N; Mohseni R; Awasty V; Cusi K; Kowdley KV; Lai M; Schiff E; Parmar D; Patel P; Chalasani N; Hepatology (Baltimore, Md.) 2021 Jul 19
Gawrieh S; Noureddin M; Loo N; Mohseni R; Awasty V; Cusi K; Kowdley KV; Lai M; Schiff E; Parmar D; Patel P; Chalasani N; Hepatology (Baltimore, Md.) 2021 Jul 19
A perspective on RNA interference-based therapeutics for metabolic liver diseases.
Alkhouri N; Gawrieh S; Expert opinion on investigational drugs 2021 Jan 29
Alkhouri N; Gawrieh S; Expert opinion on investigational drugs 2021 Jan 29
Noninvasive stratification of nonalcoholic fatty liver disease by whole transcriptome cell-free mRNA characterization.
Chalasani N; Toden S; Sninsky JJ; Rava RP; Braun JV; Gawrieh S; Zhuang J; Nerenberg M; Quake SR; Maddala T; American journal of physiology. Gastrointestinal and liver physiology 2021 Jan 27
Chalasani N; Toden S; Sninsky JJ; Rava RP; Braun JV; Gawrieh S; Zhuang J; Nerenberg M; Quake SR; Maddala T; American journal of physiology. Gastrointestinal and liver physiology 2021 Jan 27
Prevalence of High-risk Nonalcoholic Steatohepatitis (NASH) in the United States: Results From NHANES 2017-2018.
Vilar-Gomez E; Vuppalanchi R; Mladenovic A; Samala N; Gawrieh S; Newsome PN; Chalasani N; Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021 Dec 25
Vilar-Gomez E; Vuppalanchi R; Mladenovic A; Samala N; Gawrieh S; Newsome PN; Chalasani N; Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021 Dec 25
High-quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population.
Vilar-Gomez E; Nephew LD; Vuppalanchi R; Gawrieh S; Mladenovic A; Pike F; Samala N; Chalasani N; Hepatology (Baltimore, Md.) 2021 Dec 14
Vilar-Gomez E; Nephew LD; Vuppalanchi R; Gawrieh S; Mladenovic A; Pike F; Samala N; Chalasani N; Hepatology (Baltimore, Md.) 2021 Dec 14
Relationship of Enhanced Liver Fibrosis Score with Pediatric Nonalcoholic Fatty Liver Disease Histology and Response to Vitamin E or Metformin.
Gawrieh S; Harlow KE; Pike F; Yates KP; Wilson LA; Cummings OW; Rosenberg WM; Chalasani N; Molleston JP; The Journal of pediatrics 2021 Aug 13
Gawrieh S; Harlow KE; Pike F; Yates KP; Wilson LA; Cummings OW; Rosenberg WM; Chalasani N; Molleston JP; The Journal of pediatrics 2021 Aug 13
Role of candidate gene variants in modulating the risk and severity of alcoholic hepatitis.
Beaudoin JJ; Liang T; Tang Q; Banini BA; Shah VH; Sanyal AJ; Chalasani NP; Gawrieh S; Alcoholism, clinical and experimental research 2021 Apr 20
Beaudoin JJ; Liang T; Tang Q; Banini BA; Shah VH; Sanyal AJ; Chalasani NP; Gawrieh S; Alcoholism, clinical and experimental research 2021 Apr 20
Non-alcoholic Fatty Liver Disease and Diabetes Mellitus.
Khneizer G; Rizvi S; Gawrieh S; Advances in experimental medicine and biology 2021
Khneizer G; Rizvi S; Gawrieh S; Advances in experimental medicine and biology 2021
Interrogation of selected genes influencing serum LDL-Cholesterol levels in patients with well characterized NAFLD.
Vilar-Gomez E; Gawrieh S; Liang T; McIntyre AD; Hegele RA; Chalasani N; Journal of clinical lipidology 2020 Dec 27
Vilar-Gomez E; Gawrieh S; Liang T; McIntyre AD; Hegele RA; Chalasani N; Journal of clinical lipidology 2020 Dec 27
Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain.
Gourlay GK; Kowalski SR; Plummer JL; Cousins MJ; Armstrong PJ; Anesthesia and analgesia 1988 Apr
Gourlay GK; Kowalski SR; Plummer JL; Cousins MJ; Armstrong PJ; Anesthesia and analgesia 1988 Apr
American Association for Study of Liver Diseases
American Gastroenterological Association
American Board of Internal Medicine - Transplant Hepatology
American Board of Internal Medicine - Gastroenterology
American Board of Internal Medicine
Looking for patient care?
To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.